|
Volumn 38, Issue 12, 2011, Pages 2220-2223
|
[Prediction of the efficacy of modified FOLFOX6 therapy according to the mRNA levels of thymidylate synthase (TS), excision repair cross-complementing-1 and -2( ERCC-1 and ERCC-2) and methylenetetrahydrofolate dehydrogenase( MTHFD) in the primary lesion of colorectal cancer].
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DNA BINDING PROTEIN;
ENDONUCLEASE;
ERCC1 PROTEIN, HUMAN;
ERCC2 PROTEIN, HUMAN;
FLUOROURACIL;
FOLINIC ACID;
MESSENGER RNA;
METHYLENETETRAHYDROFOLATE DEHYDROGENASE;
PLATINUM COMPLEX;
THYMIDYLATE SYNTHASE;
XERODERMA PIGMENTOSUM GROUP D PROTEIN;
ADULT;
AGED;
ARTICLE;
COLORECTAL TUMOR;
FEMALE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
LIVER TUMOR;
MALE;
METASTASIS;
MIDDLE AGED;
PATHOLOGY;
ADULT;
AGED;
AGED, 80 AND OVER;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
COLORECTAL NEOPLASMS;
DNA-BINDING PROTEINS;
ENDONUCLEASES;
FEMALE;
FLUOROURACIL;
GENE EXPRESSION REGULATION, NEOPLASTIC;
HUMANS;
LEUCOVORIN;
LIVER NEOPLASMS;
MALE;
METHYLENETETRAHYDROFOLATE DEHYDROGENASE (NADP);
MIDDLE AGED;
ORGANOPLATINUM COMPOUNDS;
RNA, MESSENGER;
THYMIDYLATE SYNTHASE;
XERODERMA PIGMENTOSUM GROUP D PROTEIN;
|
EID: 84858982217
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|